Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication

NANot yet recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2030

Conditions
HELICOBACTER PYLORI INFECTIONS
Interventions
DRUG

Vonoprazan based ET

Empirical therapy Based on drug history: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or quadruple therapy

DRUG

Vonoprazan based SGT

Susceptibility testing guided therapy Based onsusceptibility test:Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin quadruple therapy

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT07130253 - Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication | Biotech Hunter | Biotech Hunter